Agency Forms Undergoing Paperwork Reduction Act Review, 52571-52572 [2022-18440]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted publicly at
www.regulations.gov, we cannot redact
or remove your comment unless you
submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding, as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before October 25, 2022. For
information on the Commission’s
privacy policy, including routine uses
permitted by the Privacy Act, see
https://www.ftc.gov/site-information/
privacy-policy.
Josephine Liu,
Assistant General Counsel for Legal Counsel.
[FR Doc. 2022–18407 Filed 8–25–22; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–22IK]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Study to
Explore Early Development (SEED)
Follow-up Study to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on October 4,
2021 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
VerDate Sep<11>2014
16:59 Aug 25, 2022
Jkt 256001
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Study to Explore Early Development
(SEED), Follow-up Study—New—
National Center on Birth Defects and
Developmental Disabilities
(NCBDDD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
In 2016, an estimated one in 54
children eight years of age living in 11
communities across the United States
had autism spectrum disorder (ASD), a
developmental disability that can cause
significant social, communication, and
behavior challenges. Total annual costs
associated with ASD have been
estimated between $11.5–60.9 billion
(2011, US dollars), yet major gaps in
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
52571
knowledge remain about risk factors for
ASD, and associated challenges and
needs for persons with ASD and their
families. Additionally, while most
research on ASD has focused on
children, ASD is considered a lifelong
condition, and although an estimated
70,000 to 111,000 youth with ASD turn
18 years of age annually, little is known
about the transition to adolescence and
adulthood for persons with ASD.
Despite the call to address transition
and lifespan issues in the Autism
CARES Acts of 2014 and 2019, only 2%
of ASD funding from 2008–2018 was
spent on lifespan issues. The 2016–2017
Interagency Autism Coordinating
Committee (IACC) Strategic Plan
highlighted the need for more
information about the services and
support needed to maximize the quality
of life for people on the autism
spectrum, especially as individuals with
ASD progress into adulthood.
The Study to Explore Early
Development (SEED) was originally
initiated to address the Children’s
Health Act of 2000, which mandated
CDC to conduct ASD surveillance and
implement research programs to address
the number, incidence, and causes of
ASD and related developmental
disabilities. SEED was a multi-phase,
multi-site, case-control study comparing
children with ASD, identified at ages 2–
5 years, to children with other non-ASD
developmental disabilities (DD), and
from the general population (POP).
SEED was initially implemented in
three phases during 2007–2021. The
current information collection request is
to conduct longitudinal follow-up
studies of SEED 1–3 participants at
older ages, thereby addressing the
priorities established in the Autism
CARES Acts of 2014 and 2019, and the
need for research highlighted in the
IACC Strategic Plan.
Given the size of the original SEED
birth cohorts and the wealth of baseline
information collected, a follow-up study
of participants can help us address the
research gaps described above. The
information collected from this study
will allow us to better understand the
developmental trajectory of children
with ASD, their health outcomes and
co-occurring conditions at older ages,
and the associated early predictors of
these outcomes, including intellectual
abilities.
The data collected in this study also
provides the opportunity to obtain
important self-reported measures of
well-being among young adults with
ASD. Recent evidence suggests that
individuals with ASD, with average to
above average levels of intellectual
functioning, may still struggle with
E:\FR\FM\26AUN1.SGM
26AUN1
52572
Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices
activities of daily living. Yet, adults
with special needs are often required to
have an intellectual disability in order
to qualify for services. This data will
allow investigators to describe the gap
between intellectual ability and daily
living skills in adolescents with ASD to
inform public policies on eligibility for
services. Additionally, because most
SEED 1 participants will reach young
adulthood (i.e., age 18 years) in years
2021–2026, data collected through this
study will provide an opportunity to
assess changes in service access and
utilization that may occur following
high school exit. This period is
particularly challenging for young
adults with ASD who can experience
poor outcomes across multiple domains
(i.e., employment, education, social
engagement, independent living, and
access to health and mental health care
service, in association with the loss of
well-integrated school-based services).
Hence, through surveying SEED 1
participants before and after their
anticipated exit from high school, data
collected through this study could
provide important information on the
loss of services and emerging issues that
can inform service delivery and
programs on the supports needed to
achieve greater independence.
Initial follow-up surveys of SEED
participants will be conducted with the
parents of the children who previously
participated in SEED because it is the
parents who provided consent for
follow-up studies. However, many
emerging issues surrounding the
transition to adulthood among
adolescents with ASD require self rather
than parental report (e.g., self-reported
symptoms of anxiety, depression,
quality of life, social camouflaging,
gender identity, sexuality, and
relationships). Therefore, children who
originally participated at age 2–5 years
who are now adolescents and young
adults, will be contacted through their
parents and asked if they wish to
provide informed consent for
participation in surveys.
CDC requests OMB approval for an
estimated 2,089 annual burden hours.
There are no costs to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Caregiver
Caregiver
Caregiver
Caregiver
Caregiver
Caregiver
.............
.............
.............
.............
.............
.............
Caregiver and
Adult Child.
Adult Child ...........
Children aged 8–
22 years and
their caregivers.
Review of enrollment call script and consent for first follow-up survey ....
First follow-up core survey of SEED 1–3 caregivers .................................
First follow-up survey supplement for caregivers of children ....................
First follow-up survey supplement for caregivers of adolescents .............
First follow-up survey supplement for caregivers of young adults ............
Review of enrollment call script and consent, and Second follow-up survey of SEED 1 caregivers.
Review of enrollment call script and consent by caregivers and young
adults.
Second follow-up survey of SEED 1 adult children ...................................
Review of enrollment and informed consent or assent, In-person assessment of intellectual abilities.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–18440 Filed 8–25–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–0666; Docket No. CDC–2022–
0101]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
lotter on DSK11XQN23PROD with NOTICES1
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
SUMMARY:
VerDate Sep<11>2014
Number of
respondents
Form name
16:59 Aug 25, 2022
Jkt 256001
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National
Healthcare Safety Network (NHSN).
This collection provides data necessary
to identify problem areas, measure the
progress of prevention efforts, and
ultimately eliminate healthcareassociated infections (HAIs) nationwide.
DATES: CDC must receive written
comments on or before October 25,
2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0101 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
2,057
1,234
411
411
411
350
1
1
1
1
1
1
10/60
40/60
20/60
20/60
20/60
10/60
165
1
10/60
165
229
1
1
30/60
90/60
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
E:\FR\FM\26AUN1.SGM
26AUN1
]]>Agencies
[Federal Register Volume 87, Number 165 (Friday, August 26, 2022)]
[Notices]
[Pages 52571-52572]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18440]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-22IK]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Study to Explore Early Development (SEED)
Follow-up Study to the Office of Management and Budget (OMB) for review
and approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on October 4,
2021 to obtain comments from the public and affected agencies. CDC did
not receive comments related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Study to Explore Early Development (SEED), Follow-up Study--New--
National Center on Birth Defects and Developmental Disabilities
(NCBDDD), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
In 2016, an estimated one in 54 children eight years of age living
in 11 communities across the United States had autism spectrum disorder
(ASD), a developmental disability that can cause significant social,
communication, and behavior challenges. Total annual costs associated
with ASD have been estimated between $11.5-60.9 billion (2011, US
dollars), yet major gaps in knowledge remain about risk factors for
ASD, and associated challenges and needs for persons with ASD and their
families. Additionally, while most research on ASD has focused on
children, ASD is considered a lifelong condition, and although an
estimated 70,000 to 111,000 youth with ASD turn 18 years of age
annually, little is known about the transition to adolescence and
adulthood for persons with ASD. Despite the call to address transition
and lifespan issues in the Autism CARES Acts of 2014 and 2019, only 2%
of ASD funding from 2008-2018 was spent on lifespan issues. The 2016-
2017 Interagency Autism Coordinating Committee (IACC) Strategic Plan
highlighted the need for more information about the services and
support needed to maximize the quality of life for people on the autism
spectrum, especially as individuals with ASD progress into adulthood.
The Study to Explore Early Development (SEED) was originally
initiated to address the Children's Health Act of 2000, which mandated
CDC to conduct ASD surveillance and implement research programs to
address the number, incidence, and causes of ASD and related
developmental disabilities. SEED was a multi-phase, multi-site, case-
control study comparing children with ASD, identified at ages 2-5
years, to children with other non-ASD developmental disabilities (DD),
and from the general population (POP). SEED was initially implemented
in three phases during 2007-2021. The current information collection
request is to conduct longitudinal follow-up studies of SEED 1-3
participants at older ages, thereby addressing the priorities
established in the Autism CARES Acts of 2014 and 2019, and the need for
research highlighted in the IACC Strategic Plan.
Given the size of the original SEED birth cohorts and the wealth of
baseline information collected, a follow-up study of participants can
help us address the research gaps described above. The information
collected from this study will allow us to better understand the
developmental trajectory of children with ASD, their health outcomes
and co-occurring conditions at older ages, and the associated early
predictors of these outcomes, including intellectual abilities.
The data collected in this study also provides the opportunity to
obtain important self-reported measures of well-being among young
adults with ASD. Recent evidence suggests that individuals with ASD,
with average to above average levels of intellectual functioning, may
still struggle with
[[Page 52572]]
activities of daily living. Yet, adults with special needs are often
required to have an intellectual disability in order to qualify for
services. This data will allow investigators to describe the gap
between intellectual ability and daily living skills in adolescents
with ASD to inform public policies on eligibility for services.
Additionally, because most SEED 1 participants will reach young
adulthood (i.e., age 18 years) in years 2021-2026, data collected
through this study will provide an opportunity to assess changes in
service access and utilization that may occur following high school
exit. This period is particularly challenging for young adults with ASD
who can experience poor outcomes across multiple domains (i.e.,
employment, education, social engagement, independent living, and
access to health and mental health care service, in association with
the loss of well-integrated school-based services). Hence, through
surveying SEED 1 participants before and after their anticipated exit
from high school, data collected through this study could provide
important information on the loss of services and emerging issues that
can inform service delivery and programs on the supports needed to
achieve greater independence.
Initial follow-up surveys of SEED participants will be conducted
with the parents of the children who previously participated in SEED
because it is the parents who provided consent for follow-up studies.
However, many emerging issues surrounding the transition to adulthood
among adolescents with ASD require self rather than parental report
(e.g., self-reported symptoms of anxiety, depression, quality of life,
social camouflaging, gender identity, sexuality, and relationships).
Therefore, children who originally participated at age 2-5 years who
are now adolescents and young adults, will be contacted through their
parents and asked if they wish to provide informed consent for
participation in surveys.
CDC requests OMB approval for an estimated 2,089 annual burden
hours. There are no costs to respondents other than their time to
participate.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Caregiver.................................... Review of enrollment call script and consent for first 2,057 1 10/60
follow-up survey.
Caregiver.................................... First follow-up core survey of SEED 1-3 caregivers....... 1,234 1 40/60
Caregiver.................................... First follow-up survey supplement for caregivers of 411 1 20/60
children.
Caregiver.................................... First follow-up survey supplement for caregivers of 411 1 20/60
adolescents.
Caregiver.................................... First follow-up survey supplement for caregivers of young 411 1 20/60
adults.
Caregiver.................................... Review of enrollment call script and consent, and Second 350 1 10/60
follow-up survey of SEED 1 caregivers.
Caregiver and Adult Child.................... Review of enrollment call script and consent by 165 1 10/60
caregivers and young adults.
Adult Child.................................. Second follow-up survey of SEED 1 adult children......... 165 1 30/60
Children aged 8-22 years and their caregivers Review of enrollment and informed consent or assent, In- 229 1 90/60
person assessment of intellectual abilities.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-18440 Filed 8-25-22; 8:45 am]
BILLING CODE 4163-18-P
